402 related articles for article (PubMed ID: 38216942)
1. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Ambrosini G; Cordani M; Zarrabi A; Alcon-Rodriguez S; Sainz RM; Velasco G; Gonzalez-Menendez P; Dando I
Cell Commun Signal; 2024 Jan; 22(1):36. PubMed ID: 38216942
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer stem cell biology.
Yu C; Yao Z; Jiang Y; Keller ET
Minerva Urol Nefrol; 2012 Mar; 64(1):19-33. PubMed ID: 22402315
[TBL] [Abstract][Full Text] [Related]
3. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
4. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting).
Ghasemi S; Xu S; Nabavi SM; Amirkhani MA; Sureda A; Tejada S; Lorigooini Z
Phytother Res; 2021 Jul; 35(7):3649-3664. PubMed ID: 33619811
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
Front Immunol; 2020; 11():1820. PubMed ID: 33013832
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
9. Oncometabolites and the response to radiotherapy.
Xiang K; Jendrossek V; Matschke J
Radiat Oncol; 2020 Aug; 15(1):197. PubMed ID: 32799884
[TBL] [Abstract][Full Text] [Related]
10. Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation.
Pandareesh MD; Kameshwar VH; Byrappa K
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):253-267. PubMed ID: 32682386
[TBL] [Abstract][Full Text] [Related]
11. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
Yegnasubramanian S; De Marzo AM; Nelson WG
Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.
Gorodetska I; Lukiyanchuk V; Peitzsch C; Kozeretska I; Dubrovska A
Int J Cancer; 2019 Dec; 145(11):2974-2985. PubMed ID: 30968962
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer.
Civenni G; Bosotti R; Timpanaro A; Vàzquez R; Merulla J; Pandit S; Rossi S; Albino D; Allegrini S; Mitra A; Mapelli SN; Vierling L; Giurdanella M; Marchetti M; Paganoni A; Rinaldi A; Losa M; Mira-Catò E; D'Antuono R; Morone D; Rezai K; D'Ambrosio G; Ouafik L; Mackenzie S; Riveiro ME; Cvitkovic E; Carbone GM; Catapano CV
Cell Metab; 2019 Aug; 30(2):303-318.e6. PubMed ID: 31130467
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance.
Frame FM; Maitland NJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108832
[TBL] [Abstract][Full Text] [Related]
18. Potential application of cell reprogramming techniques for cancer research.
Saito S; Lin YC; Nakamura Y; Eckner R; Wuputra K; Kuo KK; Lin CS; Yokoyama KK
Cell Mol Life Sci; 2019 Jan; 76(1):45-65. PubMed ID: 30283976
[TBL] [Abstract][Full Text] [Related]
19. microRNAs and Prostate Cancer.
Josson S; Chung LW; Gururajan M
Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
[TBL] [Abstract][Full Text] [Related]
20. Targeting prostate cancer stem cells for cancer therapy.
Wang G; Wang Z; Sarkar FH; Wei W
Discov Med; 2012 Feb; 13(69):135-42. PubMed ID: 22369972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
